Markets
Orange juice prices squeeze higher, as production falters

OJ prices squeeze higher, as production falters

5/31/24 11:11AM

Outta juice

There might soon be a vitamin C-shaped hole in many Americans’ breakfasts: orange juice prices are hitting all-time highs, as a series of poor harvests strain the existing supply of frozen juice futures.

Indeed, while the price of OJ has climbed at an alarming rate in recent years due to reduced production yields, this week saw frozen concentrated orange juice futures — which, with a two-year lifespan, usually help manufacturers to ease harvest shortcomings from season to season — reach a record price of $4.87 per pound. That’s roughly 5x where they were trading in 2020.

These juiced-up figures have arisen from a blend of bad weather and disease that’s long plagued the world's orange groves. Brazil has now seen 3 consecutive heatwave-hampered harvests, squeezing the output of the world’s largest producer, which accounts for ~70% of all exports. Just 3 weeks ago, research center Fundecitrus reported that Brazil was set to produce 232M boxes of oranges in the 2024-25 season, a 24% decline on the previous cycle.

And Florida, world-renowned for its oranges, won’t be able to pick up the slack. The Sunshine State has seen output decline steadily for more than 2 decades, thanks to citrus greening, hurricanes, falling yields, and a booming housing market that’s turned citrus farms into premium real estate.

With the orange segment looking increasingly bleak, farmers are exploring using alternative fruits — like mandarins, apples, and mangoes — to supplement diminishing supplies, as consumer demand for OJ remains as strong as ever.

More Markets

See all Markets
markets

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.